Shares of Tissue Regenix Group plc (LON:TRX – Get Free Report) crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 53.99 ($0.71) and traded as low as GBX 36.04 ($0.47). Tissue Regenix Group shares last traded at GBX 37.90 ($0.50), with a volume of 30,413 shares trading hands.
Tissue Regenix Group Price Performance
The company has a debt-to-equity ratio of 31.16, a current ratio of 4.03 and a quick ratio of 2.36. The stock has a 50 day simple moving average of GBX 46.87 and a 200-day simple moving average of GBX 53.76. The firm has a market cap of £33.36 million, a PE ratio of -38.20 and a beta of 1.61.
Tissue Regenix Group Company Profile
Tissue Regenix is a leading medical device company in regenerative medicine. The Company’s patented decellularisation technology (dCELL®) removes DNA and other cellular material from animal and human soft tissue, leaving an acellular tissue scaffold not rejected by the patient’s body that can be used to repair diseased or damaged body structures.
Further Reading
- Five stocks we like better than Tissue Regenix Group
- How to Profit From Growth Investing
- Shares of RH Down Nearly 40%: Where Investors Can Turn To Now
- Why Are Stock Sectors Important to Successful Investing?
- Tariffs, Spin-Out, and R2 Updates Are Positive Signs for Rivian
- Why Invest in High-Yield Dividend Stocks?
- Cathie Wood Loads Up on Baidu—Is It the Right Time to Buy?
Receive News & Ratings for Tissue Regenix Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tissue Regenix Group and related companies with MarketBeat.com's FREE daily email newsletter.
